In support of the distinction of TNBC possessing a hyper-activated cholesterol-biosynthesis program, our metabolomics analysis of a cohort of tumor tissues (218 ER+ and 33 TNBC) demonstrates that TNBC tumors had significantly higher cholesterol contents than those of ER+ ones (Fig. 1b). The gene discussed is ESR1; the disease is neoplasm.